VG081821AC Tablets for Early to Mid-stage Parkinson's Disease
VG081821AC Tablets for Early to Mid-stage Parkinson's Disease
Recruiting · NCT07725562 · Registry updated 2026-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| VG081821AC Tablets for Early to Mid-stage Parkinson's Disease | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Phase 2 / Phase 3 | 2026-09-03 | NCT07725562 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zhejiang Vimgreen Pharmaceuticals, Ltd. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Xuanwu Hospital of Capital Medical University | Beijing | China | 2 |